{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:26:42Z","timestamp":1791228402050,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>To investigate the link between carbamylated low-density lipoprotein (ca-LDL), atherogenic index of plasma (AIP), atherogenic coefficient (AC), Castelli\u2019s risk indices I and II (CRI I and II) and subclinic atherosclerosis in psoriatic arthritis (PsA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Thirty-ninepatients and 19 age, sex, body mass index matched healthy controls were included. Insulin resistance (IR) was assessed with homeostasis of model assessment-IR (HOMA-IR). Carotid intima-media thickness (CIMT) was measured at both common carotid arteries and mean CIMT was calculated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean age was 49.50\u2009\u00b1\u200911.86\u2009years and 64.1% were females in PsA group. In the PsA group, CIMT and HOMA-IR were significantly higher (<jats:italic>p<\/jats:italic>\u2009=\u20090.003,<jats:italic>p<\/jats:italic>\u2009=\u20090.043, respectively). AIP, AC, TG\/HDL, CRI-1, CRI-2 and ca-LDL levels were similar between groups. In PsA group, CIMT was positively correlated with HOMA-IR, TG\/HDL and AIP. Although ca-LDL was positively correlated with serum amyloid A (<jats:italic>r<\/jats:italic>\u2009=\u20090.744,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), no correlation was detected between ca-LDL and CIMT (<jats:italic>r<\/jats:italic>\u2009=\u20090.215,<jats:italic>p<\/jats:italic>\u2009=\u20090.195). PsA patients with IR tended to have higher ca-LDL levels than patients without IR, but this difference lacked statistical significance (33.65\u2009\u00b1\u200926.94, 28.63\u2009\u00b1\u200928.06, respectively,<jats:italic>p<\/jats:italic>\u2009=\u20090.237).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A significant increase in CIMT was seen in PsA patients without clinically evident cardiovascular disease or any traditional atherosclerosis risk factors. CIMT was correlated with HOMA-IR, TG\/HDL and AIP.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s42358-019-0096-2","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T14:03:10Z","timestamp":1573740190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?"],"prefix":"10.1186","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8816-6181","authenticated-orcid":false,"given":"Duygu","family":"Tecer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismihan","family":"Sunar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Erhan","family":"Ozdemirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Tural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Kucuksahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Sepici Dincel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebnem","family":"Ataman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"issue":"1","key":"96_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/acr.22926","volume":"69","author":"A Polachek","year":"2017","unstructured":"Polachek A, Touma Z, Anderson M, Eder L. Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies. Arthritis Care Res. 2017;69(1):67\u201374.","journal-title":"Arthritis Care Res"},{"issue":"2","key":"96_CR2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3899\/jrheum.141359","volume":"43","author":"N Haque","year":"2016","unstructured":"Haque N, Lories RJ, de Vlam K. Comorbidities associated with psoriatic arthritis compared with non-psoriatic spondyloarthritis: a cross-sectional study. J Rheumatol. 2016;43(2):376\u201382.","journal-title":"J Rheumatol"},{"issue":"4","key":"96_CR3","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.22185","volume":"66","author":"M Labitigan","year":"2014","unstructured":"Labitigan M, Bahce-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, et al. Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res. 2014;66(4):600\u20137.","journal-title":"Arthritis Care Res"},{"issue":"10","key":"96_CR4","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/acr.23171","volume":"69","author":"H Radner","year":"2017","unstructured":"Radner H, Lesperance T, Accortt NA, Solomon DH. Incidence and prevalence of cardiovascular risk factors among patients with rheumatoid arthritis, psoriasis, or psoriatic arthritis. Arthritis Care Res. 2017;69(10):1510\u20138.","journal-title":"Arthritis Care Res"},{"issue":"10","key":"96_CR5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1468-3083.2012.04706.x","volume":"27","author":"YY Chin","year":"2013","unstructured":"Chin YY, Yu HS, Li WC, Ko YC, Chen GS, Wu CS, et al. Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nation-wide study. J Eur Acad Dermatol Venereol. 2013;27(10):1262\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"96_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/acr.22144","volume":"66","author":"YC Lin","year":"2014","unstructured":"Lin YC, Dalal D, Churton S, Brennan DM, Korman NJ, Kim ES, et al. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis. Arthritis Care Res. 2014;66(1):97\u2013103.","journal-title":"Arthritis Care Res"},{"issue":"12","key":"96_CR7","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/acr.20627","volume":"63","author":"JA Husted","year":"2011","unstructured":"Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res. 2011;63(12):1729\u201335.","journal-title":"Arthritis Care Res"},{"issue":"5","key":"96_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/annrheumdis-2012-201497","volume":"72","author":"L Eder","year":"2013","unstructured":"Eder L, Jayakar J, Shanmugarajah S, Thavaneswaran A, Pereira D, Chandran V, et al. The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone. Ann Rheum Dis. 2013;72(5):715\u201320.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"96_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11926-017-0692-2","volume":"19","author":"C Sobchak","year":"2017","unstructured":"Sobchak C, Eder L. Cardiometabolic disorders in psoriatic disease. Curr Rheumatol Rep. 2017;19(10):63.","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"96_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3109\/07853890.2015.1031822","volume":"47","author":"MN Di Minno","year":"2015","unstructured":"Di Minno MN, Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, et al. Cardiovascular risk markers in patients with psoriatic arthritis: a meta-analysis of literature studies. Ann Med. 2015;47(4):346\u201353.","journal-title":"Ann Med"},{"issue":"2","key":"96_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/01.ATV.12.2.261","volume":"12","author":"J Persson","year":"1992","unstructured":"Persson J, Stavenow L, Wikstrand J, Israelsson B, Formgren J, Berglund G. Noninvasive quantification of atherosclerotic lesions. Reproducibility of ultrasonographic measurement of arterial wall thickness and plaque size. Arterioscler Thromb. 1992;12(2):261\u20136.","journal-title":"Arterioscler Thromb"},{"issue":"2","key":"96_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","volume":"21","author":"JH Stein","year":"2008","unstructured":"Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American society of echocardiography carotid intima-media thickness task force. Endorsed by the society for vascular medicine. J Am Soc Echocardiogr. 2008;21(2):93\u2013111 quiz 89-90.","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"96_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","volume":"115","author":"MW Lorenz","year":"2007","unstructured":"Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459\u201367.","journal-title":"Circulation."},{"issue":"6","key":"96_CR14","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/art.22884","volume":"57","author":"C Gonzalez-Juanatey","year":"2007","unstructured":"Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum. 2007;57(6):1074\u201380.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"96_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.autrev.2013.10.008","volume":"13","author":"J Shi","year":"2014","unstructured":"Shi J, van Veelen PA, Mahler M, Janssen GM, Drijfhout JW, Huizinga TW, et al. Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Autoimmun Rev. 2014;13(3):225\u201330.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"96_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/ki.2015.166","volume":"88","author":"FH Verbrugge","year":"2015","unstructured":"Verbrugge FH, Tang WH, Hazen SL. Protein carbamylation and cardiovascular disease. Kidney Int. 2015;88(3):474\u20138.","journal-title":"Kidney Int"},{"issue":"12","key":"96_CR17","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.autrev.2015.08.003","volume":"14","author":"MS Chimenti","year":"2015","unstructured":"Chimenti MS, Triggianese P, Nuccetelli M, Terracciano C, Crisanti A, Guarino MD, et al. Auto-reactions, autoimmunity and psoriatic arthritis. Autoimmun Rev. 2015;14(12):1142\u20136.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"96_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.jrn.2011.10.023","volume":"22","author":"EO Apostolov","year":"2012","unstructured":"Apostolov EO, Basnakian AG, Ok E, Shah SV. Carbamylated low-density lipoprotein: nontraditional risk factor for cardiovascular events in patients with chronic kidney disease. J Ren Nutr. 2012;22(1):134\u20138.","journal-title":"J Ren Nutr"},{"issue":"12","key":"96_CR19","doi-asserted-by":"publisher","first-page":"878","DOI":"10.5551\/jat.14035","volume":"20","author":"EO Apostolov","year":"2013","unstructured":"Apostolov EO, Ok E, Burns S, Nawaz S, Savenka A, Shah S, et al. Carbamylated-oxidized LDL: proatherosclerotic effects on endothelial cells and macrophages. J Atheroscler Thromb. 2013;20(12):878\u201392.","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"96_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1523-1755.2005.00391.x","volume":"68","author":"E Ok","year":"2005","unstructured":"Ok E, Basnakian AG, Apostolov EO, Barri YM, Shah SV. Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int. 2005;68(1):173\u20138.","journal-title":"Kidney Int"},{"issue":"6","key":"96_CR21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1440-1797.2008.00948.x","volume":"13","author":"G Asci","year":"2008","unstructured":"Asci G, Basci A, Shah SV, Basnakian A, Toz H, Ozkahya M, et al. Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells. Nephrology (Carlton). 2008;13(6):480\u20136.","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"96_CR22","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1161\/01.ATV.0000258795.75121.8a","volume":"27","author":"EO Apostolov","year":"2007","unstructured":"Apostolov EO, Shah SV, Ok E, Basnakian AG. Carbamylated low-density lipoprotein induces monocyte adhesion to endothelial cells through intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol. 2007;27(4):826\u201332.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"96_CR23","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665\u201373.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"96_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","volume":"34","author":"M Dobiasova","year":"2001","unstructured":"Dobiasova M, Frohlich J. The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583\u20138.","journal-title":"Clin Biochem"},{"issue":"12","key":"96_CR25","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1373\/clinchem.2004.037556","volume":"50","author":"A Brehm","year":"2004","unstructured":"Brehm A, Pfeiler G, Pacini G, Vierhapper H, Roden M. Relationship between serum lipoprotein ratios and insulin resistance in obesity. Clin Chem. 2004;50(12):2316\u201322.","journal-title":"Clin Chem"},{"issue":"7","key":"96_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia."},{"issue":"4","key":"96_CR27","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/01.STR.32.4.830","volume":"32","author":"S Homma","year":"2001","unstructured":"Homma S, Hirose N, Ishida H, Ishii T, Araki G. Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke. 2001;32(4):830\u20135.","journal-title":"Stroke."},{"issue":"1","key":"96_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.5527\/wjn.v5.i1.66","volume":"5","author":"R Scarpioni","year":"2016","unstructured":"Scarpioni R, Ricardi M, Albertazzi V. Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage. World J Nephrol. 2016;5(1):66\u201375.","journal-title":"World J Nephrol"},{"issue":"5","key":"96_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/MOL.0000000000000331","volume":"27","author":"GS Getz","year":"2016","unstructured":"Getz GS, Krishack PA, Reardon CA. Serum amyloid a and atherosclerosis. Curr Opin Lipidol. 2016;27(5):531\u20135.","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"96_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.gene.2016.02.044","volume":"583","author":"L Sun","year":"2016","unstructured":"Sun L, Ye RD. Serum amyloid A1: structure, function and gene polymorphism. Gene. 2016;583(1):48\u201357.","journal-title":"Gene."},{"issue":"24","key":"96_CR31","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","volume":"108","author":"N Sattar","year":"2003","unstructured":"Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation. 2003;108(24):2957\u201363.","journal-title":"Circulation."},{"issue":"4","key":"96_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","volume":"20","author":"WH Boehncke","year":"2011","unstructured":"Boehncke WH, Boehncke S, Tobin AM, Kirby B. The \u2018psoriatic march\u2019: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol. 2011;20(4):303\u20137.","journal-title":"Exp Dermatol"},{"issue":"7","key":"96_CR33","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/1756-185X.12444","volume":"19","author":"O Dikbas","year":"2016","unstructured":"Dikbas O, Tosun M, Bes C, Tonuk SB, Aksehirli OY, Soy M. Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity. Int J Rheum Dis. 2016;19(7):672\u20137.","journal-title":"Int J Rheum Dis"},{"issue":"12","key":"96_CR34","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1136\/annrheumdis-2012-202325","volume":"72","author":"L Eder","year":"2013","unstructured":"Eder L, Jayakar J, Pollock R, Pellett F, Thavaneswaran A, Chandran V, et al. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Ann Rheum Dis. 2013;72(12):1956\u201361.","journal-title":"Ann Rheum Dis"},{"key":"96_CR35","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/RHU.0000000000000721","volume":"24","author":"J Feld","year":"2018","unstructured":"Feld J, Nissan S, Eder L, Rahat MA, Elias M, Rimar D, et al. Increased prevalence of metabolic syndrome and adipocytokine levels in a psoriatic arthritis cohort. J Clin Rheumatol. 2018;24:302.","journal-title":"J Clin Rheumatol"},{"issue":"7","key":"96_CR36","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s00125-010-1684-1","volume":"53","author":"RA DeFronzo","year":"2010","unstructured":"DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard lecture 2009. Diabetologia. 2010;53(7):1270\u201387.","journal-title":"Diabetologia."},{"issue":"1","key":"96_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2337\/diacare.23.1.57","volume":"23","author":"E Bonora","year":"2000","unstructured":"Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23(1):57\u201363.","journal-title":"Diabetes Care"},{"issue":"3","key":"96_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.amjcard.2005.03.085","volume":"96","author":"T McLaughlin","year":"2005","unstructured":"McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96(3):399\u2013404.","journal-title":"Am J Cardiol"},{"issue":"3","key":"96_CR39","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1194\/jlr.P011668","volume":"52","author":"M Dobiasova","year":"2011","unstructured":"Dobiasova M, Frohlich J, Sedova M, Cheung MC, Brown BG. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res. 2011;52(3):566\u201371.","journal-title":"J Lipid Res"},{"issue":"5","key":"96_CR40","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4103\/0378-6323.163734","volume":"81","author":"S Sunitha","year":"2015","unstructured":"Sunitha S, Rajappa M, Thappa DM, Chandrashekar L, Munisamy M, Revathy G, et al. Comprehensive lipid tetrad index, atherogenic index and lipid peroxidation: surrogate markers for increased cardiovascular risk in psoriasis. Indian J Dermatol Venereol Leprol. 2015;81(5):464\u201371.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"96_CR41","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s10067-018-4027-0","volume":"37","author":"E Cure","year":"2018","unstructured":"Cure E, Icli A, Uslu AU, Sakiz D, Cure MC, Baykara RA, et al. Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis : AIP associate with cIMT in AS. Clin Rheumatol. 2018;37(5):1273\u201380.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"96_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12291-016-0566-9","volume":"32","author":"S Parveen","year":"2017","unstructured":"Parveen S, Jacob R, Rajasekhar L, Srinivasa C, Mohan IK. Serum lipid alterations in early rheumatoid arthritis patients on disease modifying anti rheumatoid therapy. Indian J Clin Biochem. 2017;32(1):26\u201332.","journal-title":"Indian J Clin Biochem"},{"issue":"3","key":"96_CR43","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00393-016-0141-z","volume":"76","author":"E Cure","year":"2017","unstructured":"Cure E, Icli A, Ugur Uslu A, Aydogan Baykara R, Sakiz D, Ozucan M, et al. Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behcet disease. Z Rheumatol. 2017;76(3):259\u201366.","journal-title":"Z Rheumatol"},{"issue":"3","key":"96_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5152\/eurasianjmed.2017.17143","volume":"49","author":"AU Uslu","year":"2017","unstructured":"Uslu AU, Kucuk A, Icli A, Cure E, Sakiz D, Arslan S, et al. Plasma atherogenic index is an independent Indicator of subclinical atherosclerosis in systemic lupus erythematosus. Eurasian J Med. 2017;49(3):193\u20137.","journal-title":"Eurasian J Med"},{"issue":"4","key":"96_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/0003319716659220","volume":"68","author":"A Icli","year":"2017","unstructured":"Icli A, Cure E, Uslu AU, Sakiz D, Cure MC, Ozucan M, et al. The relationship between atherogenic index and carotid artery atherosclerosis in familial Mediterranean fever. Angiology. 2017;68(4):315\u201321.","journal-title":"Angiology."},{"key":"96_CR46","first-page":"757","volume":"5","author":"J Millan","year":"2009","unstructured":"Millan J, Pinto X, Munoz A, Zuniga M, Rubies-Prat J, Pallardo LF, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757\u201365.","journal-title":"Vasc Health Risk Manag"},{"issue":"4","key":"96_CR47","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1055\/s-0036-1584918","volume":"25","author":"N Garg","year":"2016","unstructured":"Garg N, Krishan P, Syngle A. Atherosclerosis in psoriatic arthritis: a multiparametric analysis using imaging technique and laboratory markers of inflammation and vascular function. Int J Angiol. 2016;25(4):222\u20138.","journal-title":"Int J Angiol"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-019-0096-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s42358-019-0096-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-019-0096-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T22:41:24Z","timestamp":1722033684000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-019-0096-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1186\/s42358-019-0096-2","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,14]]},"assertion":[{"value":"23 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Committee on Human Research Ethics of Turkish Ministry of Health Zekai Tahir Burak Women\u2019s Health, Training and Research Hospital (decision number: 60\/2017). A well written informed consent and consent to publish was obtained from all the partipicants included in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}